Citations
165
41.3 per year
Published
2021
Effect of early treatment with hydroxychloroquine or lopinavir and ritonavir on risk of hospitalization among patients with COVID-19: the TOGETHER randomized clinical trial
JAMA Network Open•2021
Authors
G Reis, EASM Silva, DCM Silva, L Thabane, AC Ferreira, VEG Souza-Campos, AM Nogueira, APM Almeida, EDS Callegari, ADF Figueiredo-Neto, L Sprague, H Hendrickson, JI Forrest, P McKenzie, AA Gordon, K Thorlund, EJ Mills
COVID-19
Hydroxychloroquine
Abstract
Importance: Data on the efficacy of hydroxychloroquine or lopinavir-ritonavir for the treatment of high-risk outpatients with COVID-19 in developing countries are needed. Objective: To determine whether hydroxychloroquine or lopinavir-ritonavir reduces hospitalization among high-risk patients with early symptomatic COVID-19 in an outpatient setting.
Related Publications
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
The Lancet Global Health • 2022
The Lancet
COVID-19
Effect of early treatment with ivermectin among patients with Covid-19
New England Journal of Medicine • 2022
COVID-19
Ivermectin
A real-time dashboard of clinical trials for COVID-19
The Lancet Digital Health • 2020
The Lancet
COVID-19